NCT04689594
A Study to Evaluate the Esophageal Stenosis Inhibition Effects of CLS2702C/CLS2702D After Endoscopic Submucosal Dissection (ESD) in Patients With Superficial Esophageal Cancer in the Steroid Administration Risk Group
Phase: Phase 3
Role: Lead Sponsor
Start: Feb 4, 2021
Completion: Dec 20, 2023